Skip to main content
    H

    Haoxi Health Technology Limited (HAO)

    Official site

    COMMUNICATION SERVICES • ADVERTISING AGENCIES • NASDAQ

    $2.00
    -0.08 (-4.09%)

    Market Cap: $1.33M

    Last updated: Nov 17, 2026 at 10:51 AM ET

    Haoxi Health Technology Limited (HAO) Financials: Revenue, Profit and Cash Flow

    Updated Jun 30, 2026. Financial statements from company filings, amounts in US dollars.

    Haoxi Health Technology reported revenue of $32.80M for the fiscal year ended Dec 31, 2025, down 32.4% from the year before. That year, net income was $3.88M with a net margin of 11.8%, operating cash flow was -$3.36M and free cash flow was -$3.36M. The quarter ended Jun 30, 2026 had revenue of $21.00M and net income of -$2.66M.

    Revenue and Margins

    The operating margin was -6.1% in the fiscal year ended Dec 2025, the lowest of the 6 years shown. Over the 5 years to Dec 2025, revenue grew from $12.85M, a compound annual rate of 20.6%.

    Fiscal yearRevenueGrowthGross marginOperating marginNet margin
    Dec 2025$32.80M-32.4%2.8%-6.1%11.8%
    Dec 2024$48.52M0.0%5.7%3.5%2.7%
    Dec 2023$48.52M+71.9%5.7%5.7%2.7%
    Dec 2022$28.23M+74.7%7.3%4.2%3.4%
    Dec 2021$16.16M+25.8%4.0%1.7%1.5%
    Dec 2020$12.85MN/A4.7%2.6%2.4%
    Annual, fiscal years ended Dec 2020 to Dec 2025

    Income Statement

    In the fiscal year ended Dec 2025, net income rose 200.8% from the year before.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020
    Revenue$32.80M$48.52M$48.52M$28.23M$16.16M$12.85M
    Cost of revenue$31.88M$45.77M$45.77M$26.17M$15.51M$12.24M
    Gross profit$927.75K$2.75M$2.75M$2.06M$648.72K$605.58K
    Research and development$79.54K$79.98K$79.98K$58.16K$102.52K$62.65K
    Operating income-$2.00M$1.72M$2.75M$1.20M$268.77K$330.55K
    Net income$3.88M$1.29M$1.29M$969.75K$244.59K$304.06K
    EBITDA$4.57M$1.79M$2.75M$1.22M$271.77K$330.96K
    Fiscal years ended Dec 2020 to Dec 2025

    Quarterly

    Line itemJun 2026Mar 2026Sep 2025Mar 2025Sep 2024Jun 2024Dec 2023Sep 2023Jun 2023Mar 2023Dec 2022Jun 2022
    Revenue$21.00M$33.83M$8.85M$23.95M$25.02M$25.02M$23.50M$11.75M$19.07M$9.53M$9.16MN/A
    Gross profit-$967.38K$1.60M$447.36K$480.39K$1.55M$1.55M$1.20M$600.69K$1.33M$665.92K$730.23KN/A
    Operating income-$3.09M-$5.68M-$1.87M-$127.35K$898.88K$1.55M$818.37K$409.19K$703.02K$351.51K$492.79K$134.38K
    Net income-$2.66M-$6.88M$4.11M-$232.53K$531.47K$529.80K$760.20K$380.10K$522.71K$261.35K$447.05KN/A
    Last 12 quarters

    Balance Sheet

    As of Dec 2025, cash and equivalents exceeded short-term debt of $1.69M by $6.93M.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020
    Total assets$21.60M$15.51M$15.51M$4.46M$542.99K$2.81M
    Current assets$19.60M$15.38M$15.38M$3.67M$445.06K$2.63M
    Cash and equivalents$8.62M$6.66M$6.66M$1.20M$293.51K$55.89K
    Total liabilities$4.22M$4.23M$4.23M$2.90M$2.01M$4.74M
    Short-term debt$1.69M$778.35KN/A$600.95K$505.40K$266.46K
    Long-term debtN/AN/A$368.04K$249.11KN/AN/A
    Shareholder equity$17.38M$11.27M$11.27M$1.57M-$1.47M-$1.93M
    Fiscal years ended Dec 2020 to Dec 2025

    Quarterly

    Line itemJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Dec 2023Sep 2023Jun 2023
    Total assets$21.57M$20.66M$20.66M$21.60MN/A$22.07M$22.07M$15.51M$15.51M$6.17M$6.17M$4.46M
    Total liabilities$3.71M$4.70M$4.70M$4.22MN/A$3.32M$3.32M$4.23M$4.23M$4.45M$4.45M$2.90M
    Cash and equivalents$10.93M$6.80M$6.80M$8.62MN/A$9.10M$9.10M$6.66M$6.66M$1.11M$1.11M$1.20M
    Shareholder equity$17.86M$15.96M$15.96M$17.38MN/A$18.74M$18.74M$11.27M$11.27M$1.72M$1.72M$1.57M
    Last 12 quarters

    Cash Flow

    Operating cash flow was negative in the fiscal year ended Dec 2025.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020
    Operating cash flow-$3.36M-$747.58K-$747.58K-$872.13K-$675.36K$2.65M
    Capital expenditures$2$55.37K$55.37K$45.50K$8.70K$3.26K
    Free cash flow-$3.36M-$802.94K-$802.94K-$917.63K-$684.06K$2.65M
    Investing cash flow-$3.58M-$3.13MN/A-$45.50K-$8.70K-$3.26K
    Financing cash flow$8.90M$9.32M$9.32M$1.80M$933.22K-$2.61M
    Fiscal years ended Dec 2020 to Dec 2025

    Quarterly

    Line itemJun 2026Mar 2026Sep 2025Mar 2025Sep 2024Dec 2023Sep 2023Jun 2023Mar 2023Dec 2022
    Operating cash flow-$301.83K-$2.27M-$1.11M-$2.25M-$1.05M$301.00K$150.50K-$1.08M-$538.59K$205.04K
    Capital expenditures$0$4$5.14K$5.13K$39.20K$16.16K$8.08K$41.88K$20.94K$3.62K
    Free cash flow-$301.83K-$2.27M-$1.11M-$2.26M-$1.09M$284.84K$142.42K-$1.12M-$559.52K$201.42K
    Last 10 quarters

    Frequently Asked Questions About HAO

    What is Haoxi Health Technology's annual revenue?

    Haoxi Health Technology reported revenue of $32.80M for the fiscal year ended Dec 31, 2025.

    How fast is Haoxi Health Technology's revenue growing?

    Revenue was down 32.4% for the fiscal year ended Dec 31, 2025 compared with the year before. The compound annual revenue growth rate over 3 years was 5.1%.

    Is Haoxi Health Technology profitable?

    Yes. Haoxi Health Technology reported net income of $3.88M for the fiscal year ended Dec 31, 2025, with a net margin of 11.8%.

    How much free cash flow does HAO generate?

    For the fiscal year ended Dec 31, 2025, operating cash flow of -$3.36M minus capital expenditures of $2 produced free cash flow of -$3.36M.

    How much debt does Haoxi Health Technology have?

    The balance sheet dated Dec 31, 2025 reported short-term debt of $1.69M and cash and equivalents of $8.62M.